065170 — BL PharmTech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Market Cap
KR₩43bn
Enterprise Value
KR₩37bn
Revenue
KR₩25bn

Annual balance sheet for BL PharmTech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27,722	12,380	22,752	5,524	10,687
Net Total Accounts Receivable
Net Total Receivables	5,598	10,630	11,182	11,143	1,104
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	40,277	36,456	42,301	32,612	16,915
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	30,123	48,512	42,899	42,339	2,878
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	89,113	134,325	130,341	103,687	44,802
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16,658	31,731	37,000	48,979	7,965
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	43,661	68,224	71,845	69,886	13,383
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	45,453	66,102	58,497	33,800	31,419
Total Liabilities & Shareholders' Equity	89,113	134,325	130,341	103,687	44,802
Total Common Shares Outstanding